Atai Life Sciences Other Non-Cash Items 2020-2025 | ATAI

Atai Life Sciences other non-cash items from 2020 to 2025. Other non-cash items can be defined as miscellaneous non-cash adjustments to Net income.
Atai Life Sciences Annual Other Non-Cash Items
(Millions of US $)
2024 $76
2023 $-48
2022 $56
2021 $119
2020 $153
2019 $17
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.331B $0.000B
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.868B 19.58
Encompass Health (EHC) United States $12.183B 25.83
DaVita (DVA) United States $10.978B 15.44
Chemed (CHE) United States $8.483B 26.66
Elanco Animal Health (ELAN) United States $6.417B 13.74
Option Care Health (OPCH) United States $5.441B 24.25
RadNet (RDNT) United States $4.587B 291.14
Amedisys (AMED) United States $3.105B 20.89
LifeStance Health (LFST) United States $2.271B 0.00
Addus HomeCare (ADUS) United States $2.054B 22.55
Astrana Health (ASTH) United States $1.524B 37.75
U.S Physical Therapy (USPH) United States $1.213B 31.31
Aveanna Healthcare Holdings (AVAH) United States $1.169B 66.56
Pennant (PNTG) United States $1.042B 38.25
Daxor (DXR) United States $0.037B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.024B 0.00
Ontrak (OTRK) United States $0.007B 0.00
Psychemedics (PMD) United States $0.000B 0.00